John Gordan, MD, PhD is a gastrointestinal oncologist, specializing in hepatobiliary cancers such as cholangiocarcinoma, hepatocellular carcinoma, and gall bladder cancer. Dr. Gordan was born and raised in New York City. He received his undergraduate degree in biochemical sciences from Harvard University in 2001. He then completed medical and graduate training at the University of Pennsylvania in 2009, followed by Internal Medicine residency and Medical Oncology fellowship at UCSF. Dr. Gordan joined the faculty at UCSF as Clinical Instructor in 2015.
Dr. Gordan is actively involved in the design and execution of clinical trails for patients with hepatocellular carcinoma and cholangiocarcinoma. His laboratory research focuses on identifying new therapies and predictive biomarkers for improved application of existing therapies for patients with these cancers.
Below is an interview with Dr. Gordan completed in 2019.
Here, Dr. Gordan describes some of his experiences in fibrolamellar treatment in a 2017 discussion with the Rare Disease Report.